Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Cross

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Investigation|September 1, 1992
The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the ratK S Kim, H Itabashi, P Gemski, et al.
Vaccine|May 12, 2001
Unusual persistence in healthy volunteers and ill patients of hyperimmune immunoglobulin directed against multiple Pseudomonas O-chain and Klebsiella serotypes after intravenous infusionJ B McClain, R Edelman, M Shmuklarsky, et al.
The Journal of Infectious Diseases|January 1, 1988
Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivoK S Kim, J H Kang, A S Cross, et al.
Lancet (London, England)|April 21, 1984
Intravenous immune globulin: a cautionary noteA S Cross, B M Alving, J C Sadoff, et al.
Developments in Biological Standardization|January 11, 1990
Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharidesA B Lang, E Fürer, U Schürch, et al.
The Journal of Infectious Diseases|May 11, 1991
Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humansS J Cryz, A S Cross, J C Sadoff, et al.
Clinical and Diagnostic Laboratory Immunology|September 25, 1997
O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infectionsM Trautmann, M Ruhnke, T Rukavina, et al.
Infection and Immunity|May 11, 1992
Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumoniaT K Held, M Trautmann, M E Mielke, et al.
The Journal of Infectious Diseases|May 11, 1991
Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella speciesS J Cryz, E Fürer, J C Sadoff, et al.
Lancet (London, England)|December 23, 1989
Effect of race and blood group on the immune response to bacterial polysaccharide and conjugate vaccinesS J Cryz, E Fürer, T Fredeking, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|September 1, 1992
The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the ratK S Kim, H Itabashi, P Gemski, et al.
Vaccine|May 12, 2001
Unusual persistence in healthy volunteers and ill patients of hyperimmune immunoglobulin directed against multiple Pseudomonas O-chain and Klebsiella serotypes after intravenous infusionJ B McClain, R Edelman, M Shmuklarsky, et al.
The Journal of Infectious Diseases|January 1, 1988
Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivoK S Kim, J H Kang, A S Cross, et al.
Lancet (London, England)|April 21, 1984
Intravenous immune globulin: a cautionary noteA S Cross, B M Alving, J C Sadoff, et al.
Developments in Biological Standardization|January 11, 1990
Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharidesA B Lang, E Fürer, U Schürch, et al.
The Journal of Infectious Diseases|May 11, 1991
Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humansS J Cryz, A S Cross, J C Sadoff, et al.
Clinical and Diagnostic Laboratory Immunology|September 25, 1997
O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infectionsM Trautmann, M Ruhnke, T Rukavina, et al.
Infection and Immunity|May 11, 1992
Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumoniaT K Held, M Trautmann, M E Mielke, et al.
The Journal of Infectious Diseases|May 11, 1991
Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella speciesS J Cryz, E Fürer, J C Sadoff, et al.
Lancet (London, England)|December 23, 1989
Effect of race and blood group on the immune response to bacterial polysaccharide and conjugate vaccinesS J Cryz, E Fürer, T Fredeking, et al.
Pageof 12